Cargando…
High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction
Transition from cangrelor to oral P2Y12 inhibitors after PCI carries the risk of platelet function recovery and acute stent thrombosis. Whether the recommended transition regimen is appropriate for hypothermic cardiac arrest survivors is unknown. We assessed the rate of high platelet reactivity (HPR...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073541/ https://www.ncbi.nlm.nih.gov/pubmed/32098088 http://dx.doi.org/10.3390/jcm9020583 |
_version_ | 1783506641777328128 |
---|---|
author | Buchtele, Nina Herkner, Harald Schörgenhofer, Christian Merrelaar, Anne Laggner, Roberta Gelbenegger, Georg Spiel, Alexander O. Domanovits, Hans Lang, Irene Jilma, Bernd Schwameis, Michael |
author_facet | Buchtele, Nina Herkner, Harald Schörgenhofer, Christian Merrelaar, Anne Laggner, Roberta Gelbenegger, Georg Spiel, Alexander O. Domanovits, Hans Lang, Irene Jilma, Bernd Schwameis, Michael |
author_sort | Buchtele, Nina |
collection | PubMed |
description | Transition from cangrelor to oral P2Y12 inhibitors after PCI carries the risk of platelet function recovery and acute stent thrombosis. Whether the recommended transition regimen is appropriate for hypothermic cardiac arrest survivors is unknown. We assessed the rate of high platelet reactivity (HPR) after transition from cangrelor to ticagrelor in hypothermic cardiac arrest survivors. Adult survivors of out-of-hospital cardiac arrest with ST-segment elevation myocardial infarction (STEMI), who were treated for hypothermia (33 °C ± 1) and received intravenous cangrelor during PCI and subsequent oral loading with 180mg ticagrelor were enrolled in this prospective observational cohort study. Platelet function was assessed using whole blood aggregometry. HPR was defined as AUC > 46U. The primary endpoint was the rate of HPR (%) at predefined time points during the first 24 h after cangrelor cessation. Poisson regression was used to estimate the relationship between the overlap time of cangrelor and ticagrelor co-administration and the number of subsequent HPR episodes, expressed as incidence rate ratio (IRR) with 95% confidence interval (95%CI). Between December 2017 and October 2019 16 patients (81% male, 58 years) were enrolled. On average, ticagrelor was administered 39 min (IQR 5–50) before the end of cangrelor infusion. The rate of HPR was highest 90 min after cangrelor cessation and was present in 44% (7/16) of patients. The number of HPR episodes increased significantly with decreasing overlap time of cangrelor and ticagrelor co-administration (IRR 1.03, 95%CI 1.01–1.05; p = 0.005). In this selected cohort of hypothermic cardiac arrest survivors who received cangrelor during PCI, ticagrelor loading within the recommended time frame before cangrelor cessation resulted in a substantial amount of patients with HPR. |
format | Online Article Text |
id | pubmed-7073541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70735412020-03-20 High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction Buchtele, Nina Herkner, Harald Schörgenhofer, Christian Merrelaar, Anne Laggner, Roberta Gelbenegger, Georg Spiel, Alexander O. Domanovits, Hans Lang, Irene Jilma, Bernd Schwameis, Michael J Clin Med Article Transition from cangrelor to oral P2Y12 inhibitors after PCI carries the risk of platelet function recovery and acute stent thrombosis. Whether the recommended transition regimen is appropriate for hypothermic cardiac arrest survivors is unknown. We assessed the rate of high platelet reactivity (HPR) after transition from cangrelor to ticagrelor in hypothermic cardiac arrest survivors. Adult survivors of out-of-hospital cardiac arrest with ST-segment elevation myocardial infarction (STEMI), who were treated for hypothermia (33 °C ± 1) and received intravenous cangrelor during PCI and subsequent oral loading with 180mg ticagrelor were enrolled in this prospective observational cohort study. Platelet function was assessed using whole blood aggregometry. HPR was defined as AUC > 46U. The primary endpoint was the rate of HPR (%) at predefined time points during the first 24 h after cangrelor cessation. Poisson regression was used to estimate the relationship between the overlap time of cangrelor and ticagrelor co-administration and the number of subsequent HPR episodes, expressed as incidence rate ratio (IRR) with 95% confidence interval (95%CI). Between December 2017 and October 2019 16 patients (81% male, 58 years) were enrolled. On average, ticagrelor was administered 39 min (IQR 5–50) before the end of cangrelor infusion. The rate of HPR was highest 90 min after cangrelor cessation and was present in 44% (7/16) of patients. The number of HPR episodes increased significantly with decreasing overlap time of cangrelor and ticagrelor co-administration (IRR 1.03, 95%CI 1.01–1.05; p = 0.005). In this selected cohort of hypothermic cardiac arrest survivors who received cangrelor during PCI, ticagrelor loading within the recommended time frame before cangrelor cessation resulted in a substantial amount of patients with HPR. MDPI 2020-02-21 /pmc/articles/PMC7073541/ /pubmed/32098088 http://dx.doi.org/10.3390/jcm9020583 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Buchtele, Nina Herkner, Harald Schörgenhofer, Christian Merrelaar, Anne Laggner, Roberta Gelbenegger, Georg Spiel, Alexander O. Domanovits, Hans Lang, Irene Jilma, Bernd Schwameis, Michael High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction |
title | High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction |
title_full | High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction |
title_fullStr | High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction |
title_full_unstemmed | High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction |
title_short | High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction |
title_sort | high platelet reactivity after transition from cangrelor to ticagrelor in hypothermic cardiac arrest survivors with st-segment elevation myocardial infarction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073541/ https://www.ncbi.nlm.nih.gov/pubmed/32098088 http://dx.doi.org/10.3390/jcm9020583 |
work_keys_str_mv | AT buchtelenina highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT herknerharald highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT schorgenhoferchristian highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT merrelaaranne highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT laggnerroberta highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT gelbeneggergeorg highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT spielalexandero highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT domanovitshans highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT langirene highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT jilmabernd highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction AT schwameismichael highplateletreactivityaftertransitionfromcangrelortoticagrelorinhypothermiccardiacarrestsurvivorswithstsegmentelevationmyocardialinfarction |